ACRNX
Price
$14.31
Change
+$0.08 (+0.56%)
Updated
Aug 21 closing price
Net Assets
2.47B
FSMAX
Price
$117.72
Change
-$1.39 (-1.17%)
Updated
Aug 20 closing price
Net Assets
40.08B
Interact to see
Advertisement

ACRNX vs FSMAX

ACRNX vs FSMAX Comparison Chart in %
View a ticker or compare two or three
VS
ACRNX vs. FSMAX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRNX is a Buy and FSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40.1B vs. ACRNX (2.48B). FSMAX pays higher dividends than ACRNX: FSMAX (0.50) vs ACRNX (0.00). ACRNX was incepted earlier than FSMAX: ACRNX (56 years) vs FSMAX (15 years). ACRNX (0.85) is less costly to investors than FSMAX (0.04). ACRNX is a more actively managed with annual turnover of: 78.00 vs. FSMAX (23.00). FSMAX has a lower initial minimum investment than ACRNX: FSMAX (0) vs ACRNX (2000). FSMAX annual gain was more profitable for investors over the last year : 23.68 vs. ACRNX (15.68). FSMAX return over 5 years is better than : 40.14 vs. ACRNX (-14.90).
ACRNXFSMAXACRNX / FSMAX
Total Expense Ratio0.830.042,371%
Annual Report Gross Expense Ratio0.850.042,429%
Fund Existence56 years15 years-
Gain YTD9.15316.93754%
Front LoadN/AN/A-
Min. Initial Investment20000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.48B40.1B6%
Annual Yield % from dividends0.000.50-
Returns for 1 year15.6823.6866%
Returns for 3 years41.5472.7457%
Returns for 5 years-14.9040.14-37%
Returns for 10 years-22.28134.49-17%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IGAIX51.350.59
+1.16%
American Funds Intl Gr and Inc F-3
WAMVX4.940.05
+1.02%
Wasatch Micro Cap Value
RUSTX18.850.11
+0.59%
Russell Inv US Strategic Equity M
RTSGX5.740.02
+0.35%
Transamerica Small Cap Growth R6
HFDRX21.870.06
+0.28%
Hartford Schroders US MidCap Opps R3